Follow Us

Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Intellectual Property Patent Licensing and Transactions Patent Litigation

Recent Patent Trial and Appeal Board Approaches to Patent Claims on Medical Technology Implementing AI

Each decision involves reversal of a prior art rejection and contrasts with the other decisions on subject matter eligibility, revealing different PTAB approaches and results that can inform prosecution and appeal strategies.

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

This article briefly analyzes recent Patent Trial and Appeal Board (PTAB) decisions on medical technology incorporating artificial intelligence (AI). Each decision involves reversal of a prior art rejection and contrasts with the other decisions on subject matter eligibility. The innovations at issue relate to a range of medical technologies concerning anatomical location-based machine learning models to predict pathological abnormalities, operation of a robotic surgical device prompted by an intra-operative surgical recommendation, and polygenic models to predict characteristics of individuals based on genetic variants. The decisions reveal different PTAB approaches and results that can inform prosecution and appeal strategies.

This premium content is locked for The Intellectual Property Strategist subscribers only

Continue reading by getting
started with a subscription.

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS FOR INTELLECTUAL PROPERTY LAW PRACTITIONERS.
  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical analysis of developments in patent, copyright and trademark law
  • Tap into expert guidance from top intellectual property lawyers and experts

SUBSCRIBE NOW

Subscribe Now For Unlimited Access

Read These Next